the lyla nsouli foundation for children's brain cancer research
the lyla nsouli foundation for children's brain cancer research Company Information
Group Structure
View All
Industry
Activities of other membership organisations n.e.c.
Registered Address
3 burlington gardens, sixth floor, london, W1S 3EP
the lyla nsouli foundation for children's brain cancer research Estimated Valuation
Pomanda estimates the enterprise value of THE LYLA NSOULI FOUNDATION FOR CHILDREN'S BRAIN CANCER RESEARCH at £5.7k based on a Turnover of £5.9k and 0.95x industry multiple (adjusted for size and gross margin).
the lyla nsouli foundation for children's brain cancer research Estimated Valuation
Pomanda estimates the enterprise value of THE LYLA NSOULI FOUNDATION FOR CHILDREN'S BRAIN CANCER RESEARCH at £0 based on an EBITDA of £-45k and a 6.38x industry multiple (adjusted for size and gross margin).
the lyla nsouli foundation for children's brain cancer research Estimated Valuation
Pomanda estimates the enterprise value of THE LYLA NSOULI FOUNDATION FOR CHILDREN'S BRAIN CANCER RESEARCH at £1.8m based on Net Assets of £738.5k and 2.45x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Lyla Nsouli Foundation For Children's Brain Cancer Research Overview
The Lyla Nsouli Foundation For Children's Brain Cancer Research is a live company located in london, W1S 3EP with a Companies House number of 07801855. It operates in the activities of other membership organizations n.e.c. sector, SIC Code 94990. Founded in October 2011, it's largest shareholder is unknown. The Lyla Nsouli Foundation For Children's Brain Cancer Research is a established, micro sized company, Pomanda has estimated its turnover at £5.9k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Lyla Nsouli Foundation For Children's Brain Cancer Research Health Check
Pomanda's financial health check has awarded The Lyla Nsouli Foundation For Children'S Brain Cancer Research a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
5 Weak
Size
annual sales of £5.9k, make it smaller than the average company (£395.2k)
£5.9k - The Lyla Nsouli Foundation For Children's Brain Cancer Research
£395.2k - Industry AVG
Growth
3 year (CAGR) sales growth of -32%, show it is growing at a slower rate (6.4%)
-32% - The Lyla Nsouli Foundation For Children's Brain Cancer Research
6.4% - Industry AVG
Production
with a gross margin of 96.2%, this company has a comparable cost of product (96.2%)
96.2% - The Lyla Nsouli Foundation For Children's Brain Cancer Research
96.2% - Industry AVG
Profitability
an operating margin of -756.7% make it less profitable than the average company (2%)
-756.7% - The Lyla Nsouli Foundation For Children's Brain Cancer Research
2% - Industry AVG
Employees
with 1 employees, this is below the industry average (10)
- The Lyla Nsouli Foundation For Children's Brain Cancer Research
10 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- The Lyla Nsouli Foundation For Children's Brain Cancer Research
- - Industry AVG
Efficiency
resulting in sales per employee of £5.9k, this is less efficient (£53.5k)
- The Lyla Nsouli Foundation For Children's Brain Cancer Research
£53.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - The Lyla Nsouli Foundation For Children's Brain Cancer Research
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - The Lyla Nsouli Foundation For Children's Brain Cancer Research
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - The Lyla Nsouli Foundation For Children's Brain Cancer Research
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 4390 weeks, this is more cash available to meet short term requirements (142 weeks)
4390 weeks - The Lyla Nsouli Foundation For Children's Brain Cancer Research
142 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.2%, this is a lower level of debt than the average (21.8%)
1.2% - The Lyla Nsouli Foundation For Children's Brain Cancer Research
21.8% - Industry AVG
THE LYLA NSOULI FOUNDATION FOR CHILDREN'S BRAIN CANCER RESEARCH financials
The Lyla Nsouli Foundation For Children'S Brain Cancer Research's latest turnover from December 2023 is £5.9 thousand and the company has net assets of £738.5 thousand. According to their latest financial statements, we estimate that The Lyla Nsouli Foundation For Children'S Brain Cancer Research has 1 employee and maintains cash reserves of £746.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5,946 | 1,905 | 27,001 | 19,260 | 455,121 | 118,533 | 32,638 | 229,436 | 161,993 | 467,449 | 1,428,427 | 785,796 |
| Other Income Or Grants | ||||||||||||
| Cost Of Sales | ||||||||||||
| Gross Profit | ||||||||||||
| Admin Expenses | ||||||||||||
| Operating Profit | ||||||||||||
| Interest Payable | ||||||||||||
| Interest Receivable | ||||||||||||
| Pre-Tax Profit | -3,336 | -449,208 | 10,506 | -54,911 | 412,095 | 32,795 | -347,473 | -302,835 | -43,778 | 26,287 | 707,860 | 595,449 |
| Tax | ||||||||||||
| Profit After Tax | -3,336 | -449,208 | 10,506 | -54,911 | 412,095 | 32,795 | -347,473 | -302,835 | -43,778 | 26,287 | 707,860 | 595,449 |
| Dividends Paid | ||||||||||||
| Retained Profit | -3,336 | -449,208 | 10,506 | -54,911 | 412,095 | 32,795 | -347,473 | -302,835 | -43,778 | 26,287 | 707,860 | 595,449 |
| Employee Costs | 1,524 | 12,818 | 13,247 | 88,966 | 32,747 | 26,033 | 7,847 | |||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,008 | 10,537 | 20,065 | 1,275 | 4,070 | 3,040 | ||||||
| Intangible Assets | ||||||||||||
| Investments & Other | ||||||||||||
| Debtors (Due After 1 year) | ||||||||||||
| Total Fixed Assets | 1,008 | 10,537 | 20,065 | 1,275 | 4,070 | 3,040 | ||||||
| Stock & work in progress | ||||||||||||
| Trade Debtors | 10,000 | |||||||||||
| Group Debtors | ||||||||||||
| Misc Debtors | 449 | 413 | 22,239 | 636 | 492 | 13,144 | 35,658 | 19,160 | 22,897 | 65,828 | 1,680 | 15,593 |
| Cash | 746,907 | 840,063 | 1,239,598 | 1,248,816 | 1,337,079 | 964,498 | 898,997 | 1,202,991 | 1,277,013 | 1,419,382 | 1,418,340 | 584,692 |
| misc current assets | ||||||||||||
| total current assets | 747,356 | 840,476 | 1,261,837 | 1,249,452 | 1,337,571 | 977,642 | 934,655 | 1,222,151 | 1,309,910 | 1,485,210 | 1,420,020 | 600,285 |
| total assets | 747,356 | 840,476 | 1,261,837 | 1,249,452 | 1,337,571 | 978,650 | 945,192 | 1,242,216 | 1,309,910 | 1,486,485 | 1,424,090 | 603,325 |
| Bank overdraft | ||||||||||||
| Bank loan | ||||||||||||
| Trade Creditors | 173 | 858 | 1,880 | 1,123 | 16,907 | 76 | ||||||
| Group/Directors Accounts | ||||||||||||
| other short term finances | ||||||||||||
| hp & lease commitments | ||||||||||||
| other current liabilities | 8,846 | 96,880 | 84,400 | 81,663 | 255,291 | 310,345 | 309,682 | 259,233 | 24,092 | 155,766 | 103,874 | 7,800 |
| total current liabilities | 8,846 | 97,053 | 84,400 | 82,521 | 257,171 | 310,345 | 309,682 | 259,233 | 24,092 | 156,889 | 120,781 | 7,876 |
| loans | ||||||||||||
| hp & lease commitments | ||||||||||||
| Accruals and Deferred Income | ||||||||||||
| other liabilities | ||||||||||||
| provisions | ||||||||||||
| total long term liabilities | ||||||||||||
| total liabilities | 8,846 | 97,053 | 84,400 | 82,521 | 257,171 | 310,345 | 309,682 | 259,233 | 24,092 | 156,889 | 120,781 | 7,876 |
| net assets | 738,510 | 743,423 | 1,177,437 | 1,166,931 | 1,080,400 | 668,305 | 635,510 | 982,983 | 1,285,818 | 1,329,596 | 1,303,309 | 595,449 |
| total shareholders funds | 738,510 | 743,423 | 1,177,437 | 1,166,931 | 1,080,400 | 668,305 | 635,510 | 982,983 | 1,285,818 | 1,329,596 | 1,303,309 | 595,449 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | ||||||||||||
| Depreciation | 1,008 | 9,529 | 9,528 | 8,521 | 1,275 | 2,795 | 2,795 | 1,520 | ||||
| Amortisation | ||||||||||||
| Tax | ||||||||||||
| Stock | ||||||||||||
| Debtors | 36 | -21,826 | 21,603 | 144 | -12,652 | -22,514 | 16,498 | -13,737 | -32,931 | 64,148 | -13,913 | 15,593 |
| Creditors | -173 | 173 | -858 | -1,022 | 1,880 | -1,123 | -15,784 | 16,831 | 76 | |||
| Accruals and Deferred Income | -88,034 | 12,480 | 2,737 | -173,628 | -55,054 | 663 | 50,449 | 235,141 | -131,674 | 51,892 | 96,074 | 7,800 |
| Deferred Taxes & Provisions | ||||||||||||
| Cash flow from operations | ||||||||||||
| Investing Activities | ||||||||||||
| capital expenditure | -28,587 | |||||||||||
| Change in Investments | ||||||||||||
| cash flow from investments | -28,587 | |||||||||||
| Financing Activities | ||||||||||||
| Bank loans | ||||||||||||
| Group/Directors Accounts | ||||||||||||
| Other Short Term Loans | ||||||||||||
| Long term loans | ||||||||||||
| Hire Purchase and Lease Commitments | ||||||||||||
| other long term liabilities | ||||||||||||
| share issue | ||||||||||||
| interest | ||||||||||||
| cash flow from financing | -1,577 | 15,194 | 141,442 | |||||||||
| cash and cash equivalents | ||||||||||||
| cash | -93,156 | -399,535 | -9,218 | -88,263 | 372,581 | 65,501 | -303,994 | -74,022 | -142,369 | 1,042 | 833,648 | 584,692 |
| overdraft | ||||||||||||
| change in cash | -93,156 | -399,535 | -9,218 | -88,263 | 372,581 | 65,501 | -303,994 | -74,022 | -142,369 | 1,042 | 833,648 | 584,692 |
the lyla nsouli foundation for children's brain cancer research Credit Report and Business Information
The Lyla Nsouli Foundation For Children's Brain Cancer Research Competitor Analysis
Perform a competitor analysis for the lyla nsouli foundation for children's brain cancer research by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other micro companies, companies in W1S area or any other competitors across 12 key performance metrics.
the lyla nsouli foundation for children's brain cancer research Ownership
THE LYLA NSOULI FOUNDATION FOR CHILDREN'S BRAIN CANCER RESEARCH group structure
The Lyla Nsouli Foundation For Children'S Brain Cancer Research has no subsidiary companies.
Ultimate parent company
THE LYLA NSOULI FOUNDATION FOR CHILDREN'S BRAIN CANCER RESEARCH
07801855
the lyla nsouli foundation for children's brain cancer research directors
The Lyla Nsouli Foundation For Children'S Brain Cancer Research currently has 4 directors. The longest serving directors include Mr Nadim Nsouli (Oct 2011) and Mrs Simone Nsouli (Oct 2011).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Nadim Nsouli | United Kingdom | 55 years | Oct 2011 | - | Director |
| Mrs Simone Nsouli | England | 49 years | Oct 2011 | - | Director |
| Mr Walid Fakhry | England | 56 years | Feb 2012 | - | Director |
| Mr Walid Fakhry | England | 56 years | Feb 2012 | - | Director |
P&L
December 2023turnover
5.9k
+212%
operating profit
-45k
0%
gross margin
96.2%
-2.34%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
738.5k
-0.01%
total assets
747.4k
-0.11%
cash
746.9k
-0.11%
net assets
Total assets minus all liabilities
the lyla nsouli foundation for children's brain cancer research company details
company number
07801855
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
94990 - Activities of other membership organisations n.e.c.
incorporation date
October 2011
age
14
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
MHA
address
3 burlington gardens, sixth floor, london, W1S 3EP
Bank
HSBC BANK PLC
Legal Advisor
-
the lyla nsouli foundation for children's brain cancer research Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to the lyla nsouli foundation for children's brain cancer research.
the lyla nsouli foundation for children's brain cancer research Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THE LYLA NSOULI FOUNDATION FOR CHILDREN'S BRAIN CANCER RESEARCH. This can take several minutes, an email will notify you when this has completed.
the lyla nsouli foundation for children's brain cancer research Companies House Filings - See Documents
| date | description | view/download |
|---|
